Clinical Trials Logo

Walking, Difficulty clinical trials

View clinical trials related to Walking, Difficulty.

Filter by:

NCT ID: NCT06399900 Recruiting - Aging Clinical Trials

ENhancing Exercise With LIGHT to Improve Functioning in PAD

ENLIGHTEN PAD
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The ENLIGHTEN PAD Trial will collect preliminary data to test whether daily 660 nm light treatment of the lower extremities immediately before home-based walking exercise sessions improves six-minute walk distance at 4-month follow-up, compared to sham light, in people with lower extremity peripheral artery disease (PAD).

NCT ID: NCT06399809 Not yet recruiting - Aging Clinical Trials

Fisetin to Reduce Senescence and Mobility Impairment in PAD

FIRST
Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

The investigators propose a pilot randomized trial to gather preliminary data to test the hypothesis that Fisetin will reduce abundance of senescent cells in blood, skeletal muscle, and both subcutaneous and inter muscular adipose tissue and improve 6-minute walk distance in 34 people with PAD. the investigators will determine whether greater declines in abundance of cells with senescent markers are associated with greater improvement in 6-minute walk distance in people with PAD. In exploratory analyses, the investigators will assess whether Fisetin reduces SASP and novel senescent markers in adipose tissue, muscle, and/or blood.

NCT ID: NCT06247553 Recruiting - Stroke Clinical Trials

To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors

Start date: February 2, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test a gait (walking) training program in non-ambulatory (unable to walk) chronic stroke survivors. The main question it aims to answer is: • Will gait training improve the cardiovascular system in non-ambulatory chronic stroke survivors better than a sitting leg cycling exercise? Participants will walk on a treadmill with a partial body-weight support system and the gait training device. Researchers will compare with a leg-cycling exercise to see if there are significant differences in resting heart rate, systolic blood pressure (SBP), and A1c levels in the blood.

NCT ID: NCT06165016 Recruiting - Aging Clinical Trials

Far Red Light to Improve Functioning in PAD

LIGHT PAD
Start date: February 14, 2024
Phase: N/A
Study type: Interventional

The LIGHT PAD Trial is a Phase II multi-centered randomized clinical trial to collect preliminary data to test whether daily far red light treatment of the lower extremities in people with PAD improves six-minute walk distance, lower extremity perfusion, and ischemia-related damage in gastrocnemius muscle at four-month follow-up, compared to a sham control. Participants will complete 10 minutes of twice daily home treatment with either far red light or a sham light for four months.

NCT ID: NCT06137456 Completed - Clinical trials for Spinal Cord Injuries

First Report of a New Exoskeleton in Incomplete Spinal Cord Injury

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effects of exoskeletal robotic therapy and conventional exercise therapy in incomplete spinal cord injury (SCI). The main questions it aims to answer are: - Is exoskeletal robotic therapy effective in improving functional ambulation in SCI? - Is exoskeletal robotic therapy effective in enhancing Activities of Daily Living in SCI? Participants treated with either: - Exoskeletal robotic therapy along with conventional exercise therapy, or - Only conventional exercise therapy.

NCT ID: NCT06137443 Completed - Clinical trials for Spinal Cord Injuries

Enhancing Balance and Mobility in Incomplete Spinal Cord Injury

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effects of balance therapy with an overground gait trainer in incomplete spinal cord injury (SCI). The main questions it aims to answer are: - Is balance therapy with an overground gait trainer effective in improving functional ambulation in SCI? - Is balance therapy with an overground gait trainer effective in enhancing Activities of Daily Living in SCI? Participants treated with either: • Overground gait trainer along with conventional exercise therapy

NCT ID: NCT06113965 Recruiting - Stroke Clinical Trials

Neural Operant Conditioning

Start date: May 31, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if operant conditioning can reduce spasticity in order to improve walking in stroke patient. The main questions it aims to answer are: - Can participants self-regulate reflex excitability - Can participants self-regulate reflex, reduce spasticity and improve walking Participants will undergo surface stimulation to evoke spinal reflexes and will be asked to control these reflexes therefore reducing spasticity. Researchers will compare result to able bodied participants to see if [insert effects]

NCT ID: NCT06107556 Not yet recruiting - Stroke Clinical Trials

Agonist and Antagonist Muscle Activations in the Lower Limbs During Walking After Central Nervous System Injury

NEUROGAIT
Start date: October 19, 2023
Phase:
Study type: Observational

The retrospective study investigates the part of responsibility of neuromuscular disorders associated with chronic hemiparesis in walking impairment.

NCT ID: NCT06073028 Completed - Parkinson Disease Clinical Trials

Model-based Cueing-as-needed for Walking in Parkinson's Disease

GAITPARK
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Correcting of the lack of regularity in steps is a key component of gait rehabilitation in Parkinson's disease. The proposal is to introduce adaptive spatial auditory cueing (ASAC) based on verbal instruction "lengthen the step" automatically delivered when the stride length decreased below a predetermined threshold. The present study compared the effect of usual rhythmic auditory cueing versus ASAC used during a walking training in Parkinson's disease.

NCT ID: NCT06059872 Recruiting - Stroke Clinical Trials

Biomarkers of Reaction To HIIT Exercise

BReaTHE
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

Stroke survivors with lower limb disability can improve their walking speed with high-intensity interval training (HIIT) rehabilitation therapy. However, some individuals may not respond to HIIT even when fully adherent to the program. To address this, the investigators propose to build a predictive model that identifies if a Veteran with chronic subcortical stroke will improve their walking speed with HIIT by incorporating blood lactate as an early predictor of exercise response, and inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and regional cerebral blood flow (CBF) as predictors of the brain's potential to respond, while also taking into consideration other factors such as comorbidities, demographics, and fitness levels.